Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
暂无分享,去创建一个
[1] D. Selkoe,et al. New insights into cellular α-synuclein homeostasis in health and disease , 2016, Current Opinion in Neurobiology.
[2] M. Emborg,et al. α-Synuclein and nonhuman primate models of Parkinson's disease , 2015, Journal of Neuroscience Methods.
[3] Jacqueline Burré. The Synaptic Function of α-Synuclein , 2015, Journal of Parkinson's disease.
[4] P. Brundin,et al. Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation , 2015, Journal of Parkinson's disease.
[5] D. Geschwind,et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.
[6] J. Frisén,et al. Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models , 2015, Stem cell reports.
[7] M. Nielsen,et al. Retromer-Mediated Trafficking of Transmembrane Receptors and Transporters , 2015, Membranes.
[8] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[9] Michael J. Devine,et al. A cell culture model for monitoring α-synuclein cell-to-cell transfer , 2015, Neurobiology of Disease.
[10] Jennifer C. Lee,et al. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein , 2015, Proceedings of the National Academy of Sciences.
[11] C. Richter-Landsberg,et al. Inhibition of HDAC6 Modifies Tau Inclusion Body Formation and Impairs Autophagic Clearance , 2015, Journal of Molecular Neuroscience.
[12] D. D. Di Monte,et al. Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury , 2015, Acta neuropathologica communications.
[13] J. Vickers,et al. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions , 2015, Molecular and Cellular Neuroscience.
[14] B. Meier,et al. The structure of fibrils from 'misfolded' proteins. , 2015, Current opinion in structural biology.
[15] Masaki Tanaka,et al. Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils , 2015, Neurobiology of Disease.
[16] A. Recasens,et al. Alpha-synuclein spreading in Parkinson’s disease , 2014, Front. Neuroanat..
[17] J. Winkler,et al. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment , 2014, Autophagy.
[18] T. Südhof,et al. α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation , 2014, Proceedings of the National Academy of Sciences.
[19] G. Braus,et al. Interplay between Sumoylation and Phosphorylation for Protection against α-Synuclein Inclusions* , 2014, The Journal of Biological Chemistry.
[20] E. Masliah,et al. Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein , 2014, Nature Communications.
[21] H. Akiyama,et al. Pathological alpha-synuclein propagates through neural networks , 2014, Acta neuropathologica communications.
[22] E. Masliah,et al. Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models , 2014, The Journal of Neuroscience.
[23] Jacob I. Ayers,et al. Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice , 2014, Proceedings of the National Academy of Sciences.
[24] J. Trojanowski,et al. α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration , 2014, Cell reports.
[25] P. A. Lay,et al. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes. , 2014, Human molecular genetics.
[26] N. Chen,et al. Overexpression of Human E46K Mutant α-Synuclein Impairs Macroautophagy via Inactivation of JNK1-Bcl-2 Pathway , 2014, Molecular Neurobiology.
[27] D. Rubinsztein,et al. Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy , 2014, Nature Communications.
[28] S. Tenreiro,et al. Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease , 2014, PLoS genetics.
[29] S. Tenreiro,et al. Protein phosphorylation in neurodegeneration: friend or foe? , 2014, Front. Mol. Neurosci..
[30] E. Bézard,et al. Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys , 2014, Annals of neurology.
[31] P. Brundin,et al. Alpha‐synuclein transfers from neurons to oligodendrocytes , 2014, Glia.
[32] E. Ginns,et al. Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction. , 2014, Molecular genetics and metabolism.
[33] R. Teasdale,et al. The Vps35 D620N Mutation Linked to Parkinson's Disease Disrupts the Cargo Sorting Function of Retromer , 2014, Traffic.
[34] E. Masliah,et al. c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. , 2014, Human molecular genetics.
[35] S. Prusiner,et al. Transmission of multiple system atrophy prions to transgenic mice , 2013, Proceedings of the National Academy of Sciences.
[36] T. Saido,et al. Aβ secretion and plaque formation depend on autophagy. , 2013, Cell reports.
[37] P. Aebischer,et al. Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo , 2013, Proceedings of the National Academy of Sciences.
[38] F. Brodsky,et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds , 2013, Proceedings of the National Academy of Sciences.
[39] Ambra Annibali,et al. α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. , 2013, Journal of neuropathology and experimental neurology.
[40] Ssang-Goo Cho,et al. Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein , 2013, Experimental & Molecular Medicine.
[41] A. Rana,et al. Alpha-Synuclein Induces Lysosomal Rupture and Cathepsin Dependent Reactive Oxygen Species Following Endocytosis , 2013, PloS one.
[42] Anders Björklund,et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity , 2013, Proceedings of the National Academy of Sciences.
[43] P. Brundin,et al. α‐Synuclein: The Long Distance Runner , 2013, Brain pathology.
[44] K. Brunden,et al. Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy*♦ , 2013, The Journal of Biological Chemistry.
[45] E. Masliah,et al. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia , 2013, Nature Communications.
[46] W. Poewe,et al. Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia , 2013, Glia.
[47] K. Marder,et al. RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk , 2013, Neuron.
[48] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[49] V. Buchman,et al. Contrasting Effects of α-Synuclein and γ-Synuclein on the Phenotype of Cysteine String Protein α (CSPα) Null Mutant Mice Suggest Distinct Function of these Proteins in Neuronal Synapses* , 2012, The Journal of Biological Chemistry.
[50] M. Seaman. The retromer complex – endosomal protein recycling and beyond , 2012, Journal of Cell Science.
[51] E. Morignat,et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model , 2012, Neurobiology of Aging.
[52] R. Swerdlow,et al. Ubiquitin proteasome system in Parkinson's disease: A keeper or a witness? , 2012, Experimental Neurology.
[53] A. Winslow,et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers , 2012, Molecular Neurodegeneration.
[54] C. Kraft,et al. Mechanisms and regulation of autophagosome formation. , 2012, Current opinion in cell biology.
[55] Ji-Young Park,et al. Proteolytic Cleavage of Extracellular α-Synuclein by Plasmin , 2012, The Journal of Biological Chemistry.
[56] J. Trojanowski,et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.
[57] P. Brundin,et al. Can Parkinson's disease pathology be propagated from one neuron to another? , 2012, Progress in Neurobiology.
[58] M. Britschgi,et al. Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link? , 2012, Molecular Neurobiology.
[59] R. Nussbaum,et al. α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system , 2012, Journal of Neural Transmission.
[60] V. Malhotra,et al. Biogenesis of a novel compartment for autophagosome-mediated unconventional protein secretion , 2011, The Journal of cell biology.
[61] Wei Wang,et al. A soluble α-synuclein construct forms a dynamic tetramer , 2011, Proceedings of the National Academy of Sciences.
[62] Tapan P. Patel,et al. Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.
[63] A. Goldberg,et al. Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway , 2011, Proceedings of the National Academy of Sciences.
[64] P. Brundin,et al. A deadly spread: cellular mechanisms of α-synuclein transfer , 2011, Cell Death and Differentiation.
[65] K. Chung,et al. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation , 2011, Journal of the Neurological Sciences.
[66] D. Selkoe,et al. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation , 2011, Nature.
[67] M. Farrer,et al. VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.
[68] Marc N. Offman,et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.
[69] S. Kügler,et al. Sumoylation inhibits α-synuclein aggregation and toxicity , 2011, The Journal of cell biology.
[70] Chris Gardiner,et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission , 2011, Neurobiology of Disease.
[71] E. Masliah,et al. Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease , 2011, PloS one.
[72] K. Chung,et al. Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation , 2011, Brain Research.
[73] K. Chaudhuri,et al. The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[74] P. Brundin,et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. , 2011, The Journal of clinical investigation.
[75] T. Südhof,et al. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.
[76] Steve D. M. Brown,et al. α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.
[77] Fabia Febbraro,et al. Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology , 2010, The European journal of neuroscience.
[78] Masaki Tanaka,et al. Extracellular neurosin degrades α-synuclein in cultured cells , 2010, Neuroscience Research.
[79] A. Björklund,et al. Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[80] Ji-Eun Suk,et al. Non‐classical exocytosis of α‐synuclein is sensitive to folding states and promoted under stress conditions , 2010, Journal of neurochemistry.
[81] C. Masters,et al. α-Synuclein Transgenic Mice Reveal Compensatory Increases in Parkinson's Disease-Associated Proteins DJ-1 and Parkin and Have Enhanced α-Synuclein and PINK1 Levels After Rotenone Treatment , 2010, Journal of Molecular Neuroscience.
[82] Xiaohui Xu,et al. Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats , 2010, PloS one.
[83] A. Manning-Boğ,et al. Lysosomal Degradation of α-Synuclein in Vivo* , 2010, The Journal of Biological Chemistry.
[84] K. Kwon,et al. Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells , 2010, Neuroscience Letters.
[85] R. Nicoll,et al. Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis , 2010, Neuron.
[86] E. Masliah,et al. Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.
[87] T. Noda,et al. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation , 2009, Nature Cell Biology.
[88] D. Billadeau,et al. A FAM21-containing WASH complex regulates retromer-dependent sorting. , 2009, Developmental cell.
[89] E. Masliah,et al. Phosphorylation of Synucleins by Members of the Polo-like Kinase Family* , 2009, The Journal of Biological Chemistry.
[90] E. Masliah,et al. Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases , 2009, The Journal of Neuroscience.
[91] C. Warren Olanow,et al. Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions , 2009, Neurobiology of Disease.
[92] M. Cookson,et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. , 2009, The American journal of pathology.
[93] David Park,et al. Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.
[94] H. Shill,et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.
[95] Nicolas Chenouard,et al. Prions hijack tunnelling nanotubes for intercellular spread , 2009, Nature Cell Biology.
[96] A. Paetau,et al. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo , 2009, Molecular Brain.
[97] Normand L. Frigon,et al. Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System*S⃞ , 2009, Journal of Biological Chemistry.
[98] D. Standaert,et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity , 2008, Molecular Brain.
[99] S. Yen,et al. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. , 2008, Biochemistry.
[100] Kostas Vekrellis,et al. Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.
[101] He-Jin Lee,et al. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. , 2008, Biochemical and biophysical research communications.
[102] K. Jellinger. A critical reappraisal of current staging of Lewy-related pathology in human brain , 2008, Acta Neuropathologica.
[103] B. Hyman,et al. CHIP Targets Toxic α-Synuclein Oligomers for Degradation* , 2008, Journal of Biological Chemistry.
[104] A. Bagić,et al. Olfactory pathogenesis of idiopathic Parkinson disease revisited , 2008, Movement disorders : official journal of the Movement Disorder Society.
[105] H. Braak,et al. Invited Article: Nervous system pathology in sporadic Parkinson disease , 2008, Neurology.
[106] R. Hauser,et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.
[107] P. Mcgeer,et al. α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia , 2008, Neurobiology of Aging.
[108] E. Sidransky,et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) , 2008, Human mutation.
[109] Elisabet Englund,et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.
[110] I. McKeith,et al. Patterns and stages of α-synucleinopathy , 2008, Neurology.
[111] I. Alafuzoff,et al. Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance , 2008, Acta Neuropathologica.
[112] R. Szargel,et al. Monoubiquitylation of α-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells* , 2008, Journal of Biological Chemistry.
[113] Peter T Lansbury,et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. , 2008, The Journal of clinical investigation.
[114] G. Halliday,et al. The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.
[115] C. Fader,et al. Induction of Autophagy Promotes Fusion of Multivesicular Bodies with Autophagic Vacuoles in K562 Cells , 2007, Traffic.
[116] H. Braak,et al. Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.
[117] R. Piper,et al. Biogenesis and function of multivesicular bodies. , 2007, Annual review of cell and developmental biology.
[118] H. Braak,et al. Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease , 2007, Acta Neuropathologica.
[119] Julia Thom Oxford,et al. Calpain-Cleavage of α-Synuclein : Connecting Proteolytic Processing to Disease-Linked Aggregation , 2007 .
[120] Michael L. Kramer,et al. Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.
[121] J. Bonifacino,et al. Retrograde transport from endosomes to the trans-Golgi network , 2006, Nature Reviews Molecular Cell Biology.
[122] P. Fraser,et al. Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein* , 2006, Journal of Biological Chemistry.
[123] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[124] S. M. Park,et al. Proteolytic Cleavage of Extracellular Secreted α-Synuclein via Matrix Metalloproteinases* , 2005, Journal of Biological Chemistry.
[125] K. Ray Chaudhuri,et al. The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential , 2005, Current neurology and neuroscience reports.
[126] B. Hyman,et al. The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates α-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways* , 2005, Journal of Biological Chemistry.
[127] Smita Patel,et al. Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates , 2005, The Journal of Neuroscience.
[128] Olga Pletnikova,et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[129] D. Lynch,et al. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. , 2004, The Journal of biological chemistry.
[130] R. Hawkins,et al. α‐Synuclein produces a long‐lasting increase in neurotransmitter release , 2004, The EMBO journal.
[131] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[132] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[133] D. Perl,et al. Lewy-body formation is an aggresome-related process: a hypothesis , 2004, The Lancet Neurology.
[134] C. Arighi,et al. Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor , 2004, The Journal of cell biology.
[135] Takeshi Iwatsubo,et al. Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective* , 2004, Journal of Biological Chemistry.
[136] B. Ghetti,et al. Ubiquitination of α-Synuclein in Lewy Bodies Is a Pathological Event Not Associated with Impairment of Proteasome Function* , 2003, Journal of Biological Chemistry.
[137] Tsutomu Hashikawa,et al. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. , 2003, Human molecular genetics.
[138] M. Cookson,et al. α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[139] Makoto Sawada,et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains , 2003, Acta Neuropathologica.
[140] John Q. Trojanowski,et al. Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro , 2003 .
[141] P. Axelsen,et al. Role of α-Synuclein Carboxy-Terminus on Fibril Formation in Vitro† , 2003 .
[142] S. Fahn. Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.
[143] H. Braak,et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.
[144] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[145] Hitoshi Takahashi,et al. Immunohistochemical comparison of α- and β-synuclein in adult rat central nervous system , 2002, Brain Research.
[146] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[147] V. Uversky,et al. The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.
[148] L. Greene,et al. Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death , 2001, The Journal of Neuroscience.
[149] M. Spillantini,et al. α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome , 2001, FEBS letters.
[150] John Q. Trojanowski,et al. Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult , 2001, The Journal of Neuroscience.
[151] G. Sobue,et al. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease , 2001, Neuropathology and applied neurobiology.
[152] K. Chung,et al. Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein* , 2001, The Journal of Biological Chemistry.
[153] J. Dice,et al. A molecular chaperone complex at the lysosomal membrane is required for protein translocation. , 2001, Journal of cell science.
[154] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[155] R A Crowther,et al. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[156] J. Trojanowski,et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.
[157] N. Andrews,et al. Regulated secretion of conventional lysosomes. , 2000, Trends in cell biology.
[158] T Yamamoto,et al. Localization of a novel type trypsin‐like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease , 2000, Psychiatry and clinical neurosciences.
[159] S. Scheff,et al. The Plasmin System Is Induced by and Degrades Amyloid-β Aggregates , 2000, The Journal of Neuroscience.
[160] L. Meijer,et al. Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein* , 2000, The Journal of Biological Chemistry.
[161] S. Hayashi,et al. NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains , 2000, Acta Neuropathologica.
[162] W. V. Van Nostrand,et al. Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. , 1999, Biochemistry.
[163] D. Neill,et al. Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments , 1998, FEBS letters.
[164] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[165] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[166] A. Morris,et al. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. , 1998, Biochemistry.
[167] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[168] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[169] A. Cuervo,et al. A Receptor for the Selective Uptake and Degradation of Proteins by Lysosomes , 1996, Science.
[170] David F. Clayton,et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.
[171] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[172] Dice Jf. Peptide sequences that target cytosolic proteins for lysosomal proteolysis , 1990 .
[173] S. R. Terlecky,et al. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. , 1989, Science.
[174] B. Mollenhauer,et al. The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature. , 2016, Biomarkers in medicine.
[175] Keiji Tanaka,et al. Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy. , 2014, Biochimica et biophysica acta.
[176] E. Masliah,et al. Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[177] C. Dargemont,et al. Cdc48/p97, a key actor in the interplay between autophagy and ubiquitin/proteasome catabolic pathways. , 2012, Biochimica et biophysica acta.
[178] W. Schmidt,et al. Vaccination for Parkinson's disease. , 2012, Parkinsonism & related disorders.
[179] Y. Choi,et al. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson’s disease , 2012 .
[180] O. Lindvall,et al. Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease. , 2011, Journal of Parkinson's disease.
[181] A. Cuervo,et al. Protein degradation, aggregation, and misfolding , 2010, Movement disorders : official journal of the Movement Disorder Society.
[182] He-Jin Lee,et al. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. , 2008, The international journal of biochemistry & cell biology.
[183] E. Masliah,et al. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. , 2007, The American journal of pathology.
[184] Michael L. Kramer,et al. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[185] S. M. Park,et al. Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. , 2005, The Journal of biological chemistry.
[186] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[187] Leonidas Stefanis,et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. , 2004, Science.
[188] Takeshi Iwatsubo,et al. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. , 2004, The Journal of biological chemistry.
[189] J. Trojanowski,et al. Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro. , 2003, Journal of neurochemistry.
[190] J. Trojanowski,et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. , 2003, Biochemistry.
[191] Hitoshi Takahashi,et al. Immunohistochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. , 2002, Brain research.
[192] V. Uversky,et al. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. , 2002, The Journal of biological chemistry.
[193] E. Masliah,et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.
[194] J. Trojanowski,et al. Induction of alpha-synuclein aggregation by intracellular nitrative insult. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[195] L. Meijer,et al. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. , 2000, The Journal of biological chemistry.
[196] S. Hayashi,et al. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. , 2000, Acta neuropathologica.
[197] S. Scheff,et al. The Plasmin System Is Induced by and Degrades Amyloid-b Aggregates , 2000 .
[198] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[199] J. Dice,et al. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. , 1990, Trends in biochemical sciences.